Summary
Blood-brain barrier (BBB) has been neglected in pharmacological interventions of ischemic brain although it can be reached easily after systemic administration of a drug. Brain capillary endothelial cells (BCEC) may contain NMDA receptors so that the antagonist MK-80I was studied to protect BBB function. Oxygen deficiency is a main limitation during ischemia known to generate free radicals. During hypoxia and reoxygenation, an increase of radical-induced lipid peroxidation in both BCEC and astrocytes (AC) was found, accompanied by disturbances of BBB function. Therefore, the radical scavenging lazaroid U83836E was also studied. Upon hypoxia, the permeability of the barrier (BCEC and AC, cultured separately on the two sides of a filter) increased. This effect was intensified during the following reoxygenation. MK-801 and U83836E reduced the hypoxia-induced increase of permeability.
Résumé
La barrière hémato-encéphalique (BBB) a été négligée dans des interventions pharmacologiques du cerveau ischémique bien qu’il ne soit pas difficile de le démontrer après application d’un médicament. Des cellules endothéliales de cerveau (BCEC) possèdent des récepteurs NMDA de sorte que l’antagoniste MK-801 a été appliqué pour protéger la fonction de la barrière hémato-encéphalique. Un manque d’oxygène est la limitation essentielle pendant l’ischémie en produisant des radicaux libres. Pendant l’hypoxie et la reoxygenation une augmentation des taux de la péroxidation des lipides induite par des radicaux dans des BCEC et des astrocytes (AC) a été trouvée,ainsi que des modifications de la fonction de la BBB. De plus, l’aminostéroide U83836E, qui est un agent de spin-trap a été étudié. Sous hypoxie la perméabilité de la barrière formée de BCEC et de AC cultivés séparément sur les deux cotés d’un filtre a été augmentée, et le phénomène s’est intensifié après la réoxygenation.suivante. MK-801 et U83836E ont réduit le taux d’accroissement de la perméabilité provoqué par l’hypoxie.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S.M. Rothman, and J.W. Olney, Glutamate and the pathophysiology of hypoxie-ischemic brain damage, Ann. Neurol., 19: 105 - 111 (1986).
A. Volterra, D. Trotti, and G. Racagni, Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechnisms, Molec. Pharmacol., 46: 986 - 992 (1994).
S. Rehncrona, E. Westerberg, B. Akesson, and B.K. Siesjo, Brain cortical fatty acids during and following complete and severe incomplete ischemia, J. Neurochem., 38: 84 - 93 (1982).
W. Cao, J.M. Carney, A. Duchon, R.A. Floyd, and M. Cheviot), Oxygen free radical involvment in ischemia and reperfusion injury to brain, Neurosc. Lett., 88: 233 - 238 (1988).
L.L. Rubin, D.E. Hall, S. Porter. K. Barbu, C. Cannon, H.C. Horner, M. Janatpour, C.W. Liaw, K. Manning, J. Morales, L.L. Tanner, J. Tomaselli., and F. Bard, A cell culture model of the blood-brain barrier, J. Cell Biol., 115: 1725 - 1735 (1991).
R.C. Janzer, and M.C. Raff, Astrocytes induce blood-brain barrier properties in endothelial cells, Nature (London), 325: 235 - 257 (1987).
P.M. Beart, K.-A.M. Sheehan, and D.T. Manallack, Absence of N-methyl-D-aspartate receptors on ovine cerebral microvessels, J. Cereb. Blood Flow. Metab., 8: 879 - 882 (1988).
H. Koenig, J.J. Trout, A.D. Goldstone, and Ch.Y. Lu, Capillary NMDA receptors regulate blood-brain barrier function and breakdown, Brain Res., 588: 297 - 303 (1992).
T. Müller, J. Grosche, C. Ohlemeyer, and H. Kettenmann, NMDA-activated currents in Bergmann glial cells, Neuroreport, 4: 671 - 674 (1993).
J.M. Luque, and J.G. Richards, Expression of NMDA 2B receptor subunit mRNA in Bergmann glia, Glia, 13: 228 - 232 (1995).
A.-M. Lopez-Colome, A. Ortega, and M. Romo-de-Vivar, Excitatory amino acid-induced phosphoinositide hydrolysis in Müller glia, Glia, 9: 127 - 135 (1993).
I. Sommer. C. Langenaur, and M. Schachner, Recognition of Bergmann glial and ependymal cells in the mouse nervous system by monoclonal antibody, J. Cell Biol., 90:448-458 (I 981).
L.A. McNaughton, and S.P. Hunt, Regulation of gene expression in astrocytes by excitatory amino acids. Brain Res. Mol. Brain Res., 16: 261 - 266 (1992).
D.J. Wyllie, and S.G. Cull-Candy, A comparison of NMDA receptor channels in type-2 astrocytes and granule cells from rat cerebellum, J. Physiol. (London), 475: 95 - 114 (1994).
A.J. Patel, A. Hunt. R.D. Gordon, and R. Balazs, The activities of different neural cell types of certain enzymes associated with the metabolic compartmentation of glutamate, Dev. Brain Res., 4: 3 - 11 (1982).
A.M. Benjamin, Ammonia in metabolic interactions between neurons and glial, in glutamine, glutamate, and GABA in the central nervous system, (Hertz L., Kvamme E., McGeer, E.G., and Schousbe A., eds), pp. 399-414. Alan R. Liss, New York, (1983).
F.A. Tansey, M. Farooq, and W. Cammer, Glutamine synthetase in oligodendrocytes and astrocytes: New biochemical and immunocytochemical evidence, J. Neurochem., 56: 266 - 272 (1991).
F.S. Silverstein, K. Buchanan, and M.V. Johnston, Perinatal hypoxia-ischemia disrupts striatal high affinity [3H] glutamate uptake into synaptosomes, J. Neurochem., 47: 1514 - 1619 (1986).
S. Saweda, M. Higashima, and C. Yamamoto. Inhibition of high affinity uptake augment depolarizations of hippocampal neurons induced by glutamate, kainate, and related compounds, Exp. Brain Res., 60: 323 - 329 (1985).
G.J. McBean, and P.J. Roberts, Neurotoxicity of L-glutamate and D,L-threo-3-hydroxyaspartate in the rat striatum, J. Neurochem., 44: 247 - 254 (1985).
E.H.F. Wong, J.A. Kemp, T. Priestley, A.R. Knight, G.N. Woodruff, and L.L. Iversen, The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist, Proc. Natl. Acad. Sci. USA, 83: 7104 - 7108 (1986).
G. Sutherland, N. Haas, and J. Peeling, Ischemic neocortical protection with Ú74006F dose-response curve, Neurosci. Lett., 149: 123 - 125 (1986).
H. Giese, K. Mcrtsch, and I.E. Blasig, Effect of MK-801 and U83836E on a porcine brain capillary endothelial cell barier during hypoxia, Neurosci. Lett., 191: 169 - 172 (1995).
K. Mertsch, T. Crune, A. Ladhoff, and I.E. Blasig, Hypoxia and reoxygenation of brain endothelial cells in vitro: comparison of biochemical and morphological response, Cell. Mol. Biol., 41: 243 - 253 (1995).
J.B.M.M. Van Bree, A.G. De Boer. M. Danhof, L.A. Ginsel, and D.D. Breimer, Characterization of an “in vitro” blood-brain harrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. J. Pharmacol. Exp. Ther., 247: 1233 - 1239 (1988).
J. Oehlke, S. Savoly, and I.E. Blasig, Utilization of endothelial cell monolayers of low tightness for estimation of transcellular transport characteristics of hydrophilic compounds, Eur. J. Pharmac. Sci., 2: 365 - 372 (1994).
O.W. Griffith, Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine, Anal. Biochem., 106: 207 - 212 (1980).
R.F. Haseloff, I.E. Blasig, H. Meffert, and B. Ebert, Hydroxyl radical scavenging and antipsoriatric activity of benzoic acid derivatives, Free Rad. Biol. Med., 9: 111 - 115 (1990).
M.-P. Dehouck, St. Meresse, P. Delorme, J.C. Fruchart, and R. Cecchelli, An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J. Neurochem., 54: 1798 - 1801 (1990).
U. Jaehde, R. Masereeuw, A.G. De Boer, G. Fricker, J.F. Nagelkerke, J. Vonderscher, and D.D. Breimer, Quantification and visualization of the transport ofoctreotide, a somatostatin analogue, across monolayers of cerebrovascular endothelial cells, Pharmaceut. Res., 11: 442 - 448 (1994).
K. Ohno, K.D. Pettigrew, and S.I. Rapoport, Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat, Am. J. Physiol., 235:11299-11307 (1978).
W.M. Pardridge, D. Triguero, J. Yang, and P.A. Cancilla, Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier, J. Pharmacol. Exp. Then, 253: 884 - 891 (1990).
K.L. Audus, F.L. Guillot, and J.M. Braughler, Evidence for 21 aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells, Free Rad. Biol. Med., 11: 361 - 371 (1991).
J.T. Greenamyre, J.M.M. Olson, J.B. (Jr) Penney, and A.B. Young. Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate-, and kainate-sensitive glutamate binding sites, J. Pharmacol. Exp. Ther., 233. 254 - 263 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Giese, H., Mertsch, K., Haselof, R.F., Härtel, F.H., Blasig, I.E. (1996). Hypoxia and Reoxygenation of a Cellular Barrier Consisting of Brain Capillary Endothelial Cells and Astrocytes. In: Couraud, PO., Scherman, D. (eds) Biology and Physiology of the Blood-Brain Barrier. Advances in Behavioral Biology, vol 46. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9489-2_51
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9489-2_51
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9491-5
Online ISBN: 978-1-4757-9489-2
eBook Packages: Springer Book Archive